• Users Online: 187
  • Print this page
  • Email this page

 
Table of Contents
REVIEW ARTICLE
Year : 2021  |  Volume : 10  |  Issue : 6  |  Page : 252-261

Neutrophil-lymphocyte ratio in pregnancy-associated maternal complications: A review


Department of Biochemistry, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India

Date of Submission17-May-2021
Date of Decision25-Jul-2021
Date of Acceptance28-Sep-2021
Date of Web Publication30-Nov-2021

Correspondence Address:
Vijetha Shenoy Belle
Department of Biochemistry, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, 576104
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2305-0500.331262

Rights and Permissions
  Abstract 

Pregnancy associated diseases/disorders are associated with significant maternal and neonatal morbidities and mortalities. Devising/validating cost effective and easily accessible predictive, diagnostic and risk stratification markers are critical to the management and improved outcome in these diseases. Inflammation forms the backbone of most of the routinely encountered maternal complications of pregnancy. Hematological markers can be considered as a direct reflection of the systemic inflammatory milieu. Recently, the neutrophil lymphocyte ratio has been explored for its potential to assess the severity of inflammation and thus the severity of the underlying disorder. The neutrophil-lymphocyte ratio has gained scientific attention as a potential prognostic/predictive marker of acute as well as chronic inflammatory diseases including gynecological and reproductive disorders. This present study reviews the mechanistic role of neutrophils and lymphocytes in fueling or propagating the inflammatory cascades in the three most common maternal complications of pregnancy and the evidence of clinical importance of the neutrophil to lymphocyte ratio in predicting, diagnosing, and prognosticating pregnancy-associated complications.

Keywords: Neutrophil-lymphocyte ratio; Pregnancy; Preeclampsia; Gestational diabetes mellitus; Ectopic pregnancy; Inflammation


How to cite this article:
Biswas M, Belle VS, Maripini N, Prabhu K. Neutrophil-lymphocyte ratio in pregnancy-associated maternal complications: A review. Asian Pac J Reprod 2021;10:252-61

How to cite this URL:
Biswas M, Belle VS, Maripini N, Prabhu K. Neutrophil-lymphocyte ratio in pregnancy-associated maternal complications: A review. Asian Pac J Reprod [serial online] 2021 [cited 2022 Jan 18];10:252-61. Available from: http://www.apjr.net/text.asp?2021/10/6/252/331262


  1. Introduction Top


Pregnancy, a physiologically hypermetabolic state, is characterized by increased maternal plasma and altered hematological and biochemical pictures. The induced hypermetabolic and hypervolemic state is beneficial to meet the demands of the developing fetus[1],[2]. Normal pregnancy is accompanied by significant hematological changes, including physiological anemia, thrombocytopenia, and neutrophilia[3]. Hematological changes reflect immunomodulation which is central to a successful conception, fetal sustenance, and healthy maternal and neonatal outcomes. Pregnancy involves accepting a semi-allogeneic fetus; hence immune responses play a significant yet unexplained role in the so-called “immunological paradox of pregnancy”[4]. The powerful human defense system is partially tricked during pregnancy which modulates itself to provide maximum protection from environmental hazards yet circumvents immune rejection of a semi allogeneic fetus. These strategies include immune attenuation, suppression, or evasion with the maternal immunological pathways favoring diminished likelihood of activating adaptive immunity, ensuring immune activation is skewed towards immune tolerance, and facilitating the tissue remodeling required to support placental development and function[5]. The proposed mechanisms are the lack of antigen stimulation in maternal lymphocytes, peripheral (relative suppression of cell-mediated immune response accompanied by simultaneous activation of the innate immune response), and decidual (suppression of type I cytokine production) suppression of lymphocyte function along with fetal mechanisms to escape maternal immune attack[6],[7]. Hematological parameters reflect adaptive changes of pregnancy. Hence, perturbations in a hematological profile can reflect pregnancy outcomes[8].

Physiological stress in normal pregnancy is characterized by leukocytosis, which manifests as an elevated inflammatory response aimed to effectively balance physiological demands of pregnancy, ranging from immunomodulation, immunosuppression to selective immune tolerance. The significantly elevated neutrophils in pregnancy are attributed to impaired neutrophil apoptosis. The pregnancy-induced alteration in lymphocytes, the defensive cells, remains controversial. A study suggested that lymphocyte counts might increase during pregnancy as a protective measure against infections. However, studies by Eledo et al reported gradual lymphocyte suppression with progress in gestational age[9]. In contrast, Chandra et al reported a decrease in lymphocyte count during the first and second trimesters and a subsequent increase in the third trimester[10]. The observed lymphopenia is hypothesized to be due to monocytosis ensuring immune tolerance and preventing fetal rejection[3].

Systemic inflammation can be measured by using a variety of biochemical and hematological markers. Recent evidence indicates that measuring the ratio of blood cell subtypes, such as the neutrophil-to-lymphocyte ratio (NLR), might have prognostic significance for diseases related to chronic low-grade inflammation[11].

NLR is an inexpensive inflammatory ratio that can be easily calculated from a simple blood count. Due to the ease of arriving at the ratio and the fundamental nature reflecting an inflammatory load, it is frequently evaluated as a prognostic factor in several medical disciplines[12]. Clinically, a high value has been associated with advanced disease[13]. In the gynecology and obstetrics literature, NLR has been evaluated in gynecological cancers, ovarian hyperstimulation syndrome, premature ovarian insufficiency, endometriosis, hyperemesis gravidarum, gestational diabetes, preeclampsia, pregnancy-associated intrahepatic cholestasis, etc[12]. NLR has been used as a predictive tool for maternal and neonatal outcomes[14]. This review focuses on the role of NLR in adverse pregnancy outcomes: preeclampsia, gestational diabetes mellitus (GDM), and ectopic pregnancy.

A comprehensive search (including research articles published till May 2021) was performed in the following scientific databases: PubMed/MEDLINE (USNLM), Scopus (ELSEVIER) and Web of Science to find all relevant articles on NLR in reproduction. The search strategy included the keywords such as: “preeclampsia”, “NLR”, “gestational diabetes mellitus”, “hemolysis, elevated liver enzymes, low platelets (HELLP) count syndrome”, “ectopic pregnancy”, “inflammation” which were combined using Boolean operators. Also, a random search in Google, Google scholar was conducted to obtain published articles on mechanism of neutrophil and lymphocyte perturbation or significance of NLR in disorders of pregnancy and reproduction.


  2. NLR in preeclampsia Top


2.1. Preeclampsia and HELLP syndrome

Preeclampsia, a common gestational disorder, is clinically diagnosed by new-onset hypertension developing after 20 weeks of gestation (systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg) with or without proteinuria. In the absence of proteinuria, a diagnosis of preeclampsia is made in the presence of one or more of the cardinal signs, i.e., thrombocytopenia, renal insufficiency, elevated liver enzymes, pulmonary edema, cerebral, or visual disturbances. Preeclampsia and its associated complications (HELLP syndrome & eclampsia) remain one of the leading causes of maternal and perinatal morbidity and mortality[15],[16].

Traditionally, preeclampsia is considered to progress through a “two-stage” theory; an abnormal spiral artery remodeling in early pregnancy causes placental hypoxia (stage 1) and the ischemic placenta releasing large amounts of soluble factors, such as reactive oxygen species (ROS), proinflammatory cytokines, and anti-angiogenic factors, into the maternal circulation, leading to the clinical manifestations and complications of the disease (stage 2)[15].

Evidence reiterates the presence of an exaggerated inflammatory response (abnormal cytokine production and neutrophil activation) and attributes the immune imbalance to the clinical manifestations of preeclampsia[15],[17]. NLR, a simple marker of inflammation, is being widely assessed for its diagnostic, staging, prognostic and predictive potential in preeclampsia and associated hypertensive disorders of pregnancy.

2.2. Neutrophils in preeclampsia

2.2.1. Increase in the number of neutrophils

Numerous studies indicate leukocyte and neutrophil counts (leukocytosis, evidence of increased inflammatory response) were slightly elevated in mild preeclampsia, while severe preeclampsia is characterized by marked elevation of neutrophils. Inflammatory mediators [interleukin (IL)-6, tumor necrosis factor (TNF)-alpha] are attributed to the occurrence of neutrophilia and it is reported that neutrophilia is also associated with the disease severity, progression to HELLP syndrome, reversible posterior encephalopathy syndrome, and adverse maternal and fetal outcomes[18].

2.2.2. Delayed apoptosis

Delayed neutrophil apoptosis triggered by a heightened inflammatory response is believed to contribute to neutrophilia during pregnancy and preeclampsia. It is yet to be determined if delayed apoptosis is a compensatory reaction or exaggerated response to the severity of the disease. Studies are needed to determine the degree of delayed neutrophil apoptosis and its contribution to endothelial activation or dysfunction observed in preeclampsia.

This observed resistance to neutrophil apoptosis is also postulated to partly explain why the clinical syndrome of preeclampsia persists even after expulsion of the placenta (initiating stimulus) post cesarean section and draws similarities between preeclampsia and the systemic inflammatory immune response[18],[19],[20].

2.2.3. Neutrophil activation

Evidence supporting marked neutrophil activation mimicking systemic inflammatory response syndrome in preeclampsia has been directly implicated in hepatic necrosis, adult respiratory distress syndrome, and associated organ damages[20].

Neutrophil activation requires binding and transmigration of neutrophils through the endothelium. Neutrophil recruitment in the endothelium involves P-selectin and the release of platelet-activating factors from the endothelium. Potential mechanisms of neutrophil activation include upregulation of cellular adhesion molecules, increased generation of TNF-alpha, and endothelial activation. IL-6 and endothelin-1 activate neutrophils for superoxide production and contribute to arteriopathy and endothelial damage. Once activated, neutrophil undergoes degranulation, which in turn mediates vascular damage. Further, leukotrienes are synthesized, and superoxide is generated in a respiratory burst. Superoxide anions initiate lipid peroxidation and consequently endothelial cell lysis. However, it is still undetermined if activation of neutrophils is the cause or the consequence of endothelial damage[21].

2.2.4. NETosis

Neutrophil extracellular traps (NETs) were first implicated in preeclampsia with the detection of increased NETs in the intervillous space of placentae derived from patients (the first evidence indicating that NETs may be associated even with non-infectious human pathologies). Experimental studies have reported that placental debris activates polymorphic neutrophils in vitro and triggers the generation of NETs in a time and dose-dependent manner[22].

NETs have been detected in the intervillous space of normal placentae, too. However, preeclamptic placentae showed drastically elevated NETs (in few cases appearing to fill the entire intervillous space). NETs also contribute to the widespread systemic damage to the maternal endothelium observed in preeclampsia. However, it is currently unclear whether NETs represent an initiating lesion in preeclampsia are the result of another underlying placental deficiency[22].

2.3. Lymphocytes in preeclampsia

The immuno-tolerant state of the mother in normal pregnancy is changed to cellular hyperreactivity in preeclampsia. Various arms (innate as well as adaptive) of the immune systems undergo alterations (partial inactivation of attack arms and over activation of tolerance arms) to induce an immune tolerogenic shift to protect fetus from rejection and culmination of a successful pregnancy. This delicate toloregenic shift/dip is disrupted/perturbed in preeclampsia, resulting in an inappropriately overactive immune system. This disbalance leads to inappropriate placentation, growth and leads to the development of feto-restrictive and materno-toxic hypertensive environment in preeclampsia[23].

2.3.1. Role of T lymphocytes in preeclampsia

T lymphocyte perturbations commonly implicated in preeclampsia are as follows: a) low regulatory T cell (Treg) activity; b) shift towards T helper cell (Th-1) responses; c) presence of Th-17 lymphocytes[24]. It is hypothesized that the physiological shift from a Th1 to a Th2 phenotype at the fetal-maternal interface appears to be absent/disturbed in this syndrome[25].

Studies have reported reduced numbers and functional capacity of Tregs in preeclampsia compared with normal pregnancies[25],[26]. Increased levels of serum endoglin could block transforming growth factor signals essential for Treg functions[27]. The predominance of Th17 cells in preeclampsia, the concomitant decrease in Treg function, and the resultant altered balance in the Th17: Treg ratio may be triggered by perturbations in circulating cytokines (IL-6 and IL-1)[25]. The reticular activating system functional elements of T lymphocytes produce angiotensin-2 at sites of inflammation, promoting chemotaxis of natural killer cells and T cells [Figure 1].
Figure 1: Role of T cells in preeclampsia. Tc: cytotoxic T cells; Th: T helper cells; Treg: regulatory T cell; IL: interleukin, INF: interferon; TNF: tumour necrosis factor; STAT: signal transducers and activators of transcription; TGF: transforming growth factor; PGE2: prostaglandin E2; ROR: retineic acid receptor related orphan nuclear receptor; FOXp3: forkhead box p3.

Click here to view


2.3.2. Role of B lymphocytes in preeclampsia

B lymphocytes play a vital role in the tailored immune mechanisms (the balance between protection and tolerance towards a semiallogenic fetus) essential for a successful pregnancy[28]. Protective antibodies such as antipaternal antibodies (antibodies directed to paternal HLA antigens) are essential to ensure a successful pregnancy, the absence of which leads to recurrent spontaneous abortions[29].

A successful pregnancy is also marked by increased production of asymmetric antibodies and immunoglobulin G (IgG) characterized by post-transcriptional addition of a high mannose oligosaccharide group in one Fab fragment, hindering effective bivalent antigen-antibody binding. These asymmetric antigens with relatively high affinity but altered binding properties fail to form insoluble antigen-antibody complexes and hence cannot activate immune effector functions (complement fixation, phagocytosis, and cytotoxicity) rendering increased immune tolerance[29].

Further, pregnancy favors increased differentiation of Breg cells (IL-10 producing immunoregulatory cells) and marginal zone B cells (compensatory strategy to ensure adequate defense)[30],[31].

However, perturbation in B cell functions and resultant alloantibodies has been associated with obstetric complications[28]. Hence, controlled suppression of B cell lymphopoiesis and the subsequent B cell lymphopenia are proposed to be the fundamental mechanisms to ensure immune tolerance during pregnancy[30],[31].

2.4. Presence of self-reactive B lymphocytes

2.4.1. B lymphocytes secreting antiphospholipid antibodies

Antiphospholipid antibodies (lupus anticoagulant, anticardiolipin antibodies, anti-beta2-glycoprotein-I) have been associated with several adverse obstetrics outcomes (intrauterine fetal death, spontaneous abortions, deep vein thrombosis, and preeclampsia). Antiphospholipid syndrome is a hypercoagulable state that triggers blood clots/thrombosis, leading to significantly high adverse maternal and fetal outcomes[29].

2.4.2. Angiotensin II type I receptor autoantibodies producing B lymphocytes

B cells are implicated in preeclampsia due to the production of autoantibodies against adreno-receptors and AT1-R[22]. AT1 autoantibodies (IgG isotype) are seen in 70%–95% of women with preeclampsia. These antibodies bind to trophoblast and vascular cells receptors, inducing the production of soluble Fms-like tyrosine kinase-1 and serum endoglin. Stimulation of the IL-6 production induces endothelin-1. AT1-AA binds with a relatively high affinity to the AT1 receptor and mimics the natural ligand of the angiotensin type I receptor[29].

AT1 autoantibodies may also promote vasoconstriction and hypertension. AT1 antibodies cross the placental barrier and contribute to intrauterine growth restriction by inducing apoptosis in the placenta. Adreno-receptor autoantibodies have been demonstrated in severe preeclampsia[25]. Further studies should aim to identify triggers and mechanisms by which these antibodies act in severe preeclampsia.

2.4.3. Upregulation of B cell activation factor (BAFF) and perturbations in Breg cell concentration/functions

BAFF, a cytokine essential for B cell survival and differentiation (Breg cells to naïve B cells), critically modulates B cell function during pregnancy[28]. Although low in circulation, alterations in numbers and function of Breg cells (aids in the prevention of auto/ alloantibodies, induction/maintenance of Tregs, modification of T helper cell responses, inhibition of effector cell responses) have been extensively explored and implicated in systemic and neuro-immunological autoimmune diseases, graft rejection and cancers; hence alterations in Breg differentiation signaling ought to be critical to the complex immune balance of pregnancy[32],[33].

Further, BAFF is shown to promote CD19+CD5+B1 cell survival, source of polyreactive antibodies (murine model), which are known to produce AT1 AA implicated in preeclampsia[28],[29]. Maternal serum BAFF is reported to decrease with the initiation of pregnancy and continues to further decrease with advancing gestation (ensuring quiescence of autoreactive/alloreactive B cells)[28],[32]. It is reported that BAFF circulating levels are elevated since the first trimester of pregnancy in patients developing hypertensive disorders of pregnancy[28].

2.4.4. Effect of hormonal dysregulation on B cells

High circulating levels of human chorionic gonadotropin (hCG) have been strongly associated with perturbed CD19+CD5+ in in-vitro models. CD19+CD5+ cells express many hCG receptors, and higher placental hCG levels characterize preeclampsia. CD19+CD5+ cells have also been implicated in the production of AT1 AA[34],[35].

2.5. Significance of NLR in preeclampsia

Hematological perturbations have been recognized as systemic inflammatory response markers and may have predictive and prognostic value in inflammatory diseases and preeclampsia[18]. The above-explained mechanisms make neutrophils and lymphocytes essential determinants of the preeclampsia pathophysiology. Neutrophilia (due to increased production, activation & decreased apoptosis) and imbalances in the lymphocyte population together seem to account for an increased NLR ratio in preeclampsia. A study by Sachan et al showed a significantly higher NLR ratio in preeclampsia when compared to healthy controls, even in early pregnancy[36]. In contrast, a study by Yucel et al reported a significantly lower platelet lymphocyte ratio (PLR) ratio in severe preeclampsia compared to the controls but no significant differences in NLR ratios[37]. While NLR is reported to be significantly high in patients with preeclampsia, establishing robust cut-offs for classification of the severity needs future extensive studies[38] [Figure 2].
Figure 2: Neutrophil to lymphocyte ratio in preeclampsia. TNF alpha: tumour necrosis factor alpha; IL-6: interleukin 6; Cyt C: cytochrome C; AT1 receptors: angiotensin II type I receptors; sFlt: soluble fms-like tyrosine kinase 1; sEng: serum endoglin; HTN: hypertension; Th: T helper cells; IUGR: intrauterine growth retardation.

Click here to view


Kang et al suggest that NLR might be a useful laboratory marker for clinical prediction and evaluation of disease severity in preeclampsia. However, the authors also highlight the fact that available pieces of evidence are drawn from case-control studies. Therefore, prospective cohort studies are essential to accurately determine the utility of NLR, the optimal timing of analysis, and predictive cutoff values in clinical settings[39]. Sanchan et al reported that NLR was higher among women with preeclampsia when compared to healthy pregnant women even at early gestation and NLR at a cutoff value of >3.35 showed a significant diagnostic accuracy between the controls and mild preeclamptic women with an area under curve (AUC) of 0.75, 52.9% sensitivity and 74.5% specificity. A cutoff value of NLR 3.42 could effectively differentiate between mild and severe preeclampsia with a sensitivity of 81.3%, specificity of 64.7%, and AUC of 8.94[36]. According to Kirbas et al, NLR at 4.01 cut-off accurately predicted preeclampsia with sensitivity, specificity rates of 79.1% and 38.7%, positive and negative predictive values of 73.6% and 72.3%, and AUC of 0.568[40]. Kurtoglu et al showed NLR at 4.48 cut off predicted preeclampsia with 57.7% sensitivity, 63% specificity, 73.5% positive predictive value, 455% negative predictive value, 59.6% accuracy, and an area under curve (AUC) of 0.596[41]. Oylumlu et al reported that increased NLR and echocardiographic epicardial fat thickness were independent predictors of preeclampsia with 83.3% sensitivity, 81.5% specificity at NLR ≥4.1. with 0.925 AUC[42].

NLR >5.6 at early second trimester has been reported to predict the development of preeclampsia with a sensitivity of 73.4% and a specificity of 88.6%, and severe preeclampsia with sensitivity 93.3% and specificity 86.6%, respectively[43].

A study reported that NLR [(odds ratio (OR) 1.43] and PLR (OR 1.38) emerged as most powerful predictors of preeclampsia on multivariate analysis with an AUC of 0.716 and 0.705 for NLR and PLR, respectively. The cut-off value of NLR ≥3.08 predicted preeclampsia with the sensitivity of 74.6% and specificity of 70.1% respectively[44]. Another meta-analysis by Wen et al reported a pooled sensitivity and specificity of 0.74 and 0.64 and diagnostic OR of 8.44 with 0.82 AUC. The authors added that the sample size of the studies was the primary source of heterogeneity, which appropriately concluded that as per evidence, NLR has unsatisfactory specificity but acceptable sensitivity for the diagnosis of preeclampsia. Extensive prospective cohort studies are required to validate the utility of NLR in preeclampsia[45].


  3. NLR in gestational diabetes mellitus (GDM) Top


3.1. GDM

GDM is a unique and transient form of glucose intolerance exclusive to pregnancy. GDM can lead to adverse pregnancy outcomes. Recent evidence demonstrates that GDM is an inflammatory condition involving unbalanced cytokine production. Low-grade chronic inflammation-inducing insulin dysfunction (e.g., defects in insulin sensitivity or inadequate B-cell compensation for insulin resistance) is considered as the leading cause of GDM pathogenesis[46]. The insulin post-receptor and inflammatory cytokine signaling pathways interact to block the normal tyrosine phosphorylation of the insulin receptor substrate by inducing serine/threonine phosphorylation of insulin receptor substrate. Phosphorylation of insulin receptor substrate reduces its ability to bind the insulin receptor, altering adequate glucose homeostasis. Accumulated metabolites derived from deranged glucose and lipid metabolism increases ketogenesis, enhances the release of inflammatory factors, and aggravates insulin resistance[47].

3.2. Neutrophils in GDM

Neutrophils, the first line of defense, are perturbed and increase vulnerability to opportunistic infections in patients with diabetes mellitus. Studies in patients and experimental organisms demonstrate defects of neutrophil chemotactic, phagocytic and microbicidal activities. Other alterations include increased protein leakage, reduced mast cell degranulation, impairment of neutrophil adhesion and migration, production of free radicals, decreased release of cytokines and prostaglandins by neutrophils, and increased leukocyte apoptosis. Metabolic alterations implicated in neutrophil dysfunction include discrepancies in the advanced protein glycosylation, polyol pathway, ROS, and the glycolytic and glutaminolytic pathways[48].

3.2.1. Enhanced release of neutrophil proteases and formation of NETs

GDM is associated with an altered neutrophil response, characterized by excessive pro-NETotic activity. Reports suggest that hyperglycemic states promote a pro-NETotic state. Data report an elevated circulatory TNF alpha level in GDM patients compared to the normoglycemic healthy pregnant women. Evidence indicates that circulatory TNF alpha plays a crucial role in mediating neutrophil activation in cases with GDM. TNF alpha can promote neutrophil migration, facilitating increased placental infiltration, where the primed neutrophils would readily undergo NETosis or degranulation. Exogenously liberated neutrophil elastase causes disturbances in physiological proliferation and increases insulin resistance, explaining pathological alterations like increased fetal size and villous immaturity. In addition, fibrin thrombi have been detected in the syncytiotrophoblast of placentae affected by GDM. Thus, GDM is associated with overt neutrophil activity, resulting in placental infiltration, enhanced NET formation, and neutrophil elastase release, which can profoundly alter placental cell biology via the enzymatic degradation of key regulatory signal transduction components[46],[49].

3.2.2. Persistent neutrophil activation

A study reports significantly increased neutrophil and monocyte counts in the GDM patients when compared to normal pregnancies. This has been attributed to the exaggerated activation of circulating immune cells that promote inflammation and immune dysfunction. Increased cyclic adenosine monophosphate concentration in β islet cells induced by high glucose promotes neutrophil differentiation and aggregation through the mitochondrial respiratory pathway, further promoting IL-6, ROS, and leukotriene B4 production to contribute to the development of insulin resistance[47].

3.3. Lymphocytes in GDM

Some studies have concluded that insulin resistance may be related to altered signal transduction due to decreased number of T cells[50]. In pregnant women, high plasma glucose may lead to dysregulation of the adipo-insulin axis. Monocyte chemoattractant protein 1 (MCP-1) is upregulated by free fatty acids in high glucose conditions, thus inducing MCP-1-mediated pathologic inflammation and monocyte recruitment. Increased serum very low-density lipoprotein inhibits lymphocyte proliferation by disrupting DNA synthesis, possibly explaining the more pronounced reduction of lymphocyte cell counts in the GDM group with more severe glucose elevations[47].

3.4. Significance of NLR in GDM

A significant relationship between NLR and blood glucose regulation has been reported in type II diabetes mellitus; elevated NLR may indicate underlying impaired glucose metabolism, which displays similar pathogenesis to GDM[47] [Figure 3].
Figure 3: Neutrophil to lymphocyte ratio in gestational diabetes mellitus. cAMP: cyclic adenosine monophosphate; FFA: free fatty acids; VLDL: very low density lipoprotein; IL-6: interleukin 6; ROS: reactive oxygen species; LT-B4: leukotriene B4.

Click here to view


Subclinical inflammation and cytokine-induced insulin resistance are the core inflammatory response mechanisms related to GDM[3],[4]. Pattanathaiyanon et al found a significant impact of increased white blood cell counts on GDM development[14]. Increased NLR in GDM patients has been demonstrated in this study, with elevated NLR levels being proportional to serum glucose. Receiver operating characteristic curve analysis showed better diagnostic performance of NLR than other risk factors in distinguishing GDM from control pregnancies. However, NLR showed low sensitivity, possibly because the threshold of inflammatory/immune responses is elevated even in normal pregnancies, which calls for the development of gestational age-adjusted reference intervals for NLR. A study shows that NLR >4.394 is significantly associated with maternal complications, adverse neonatal outcomes, and preterm delivery, indicating that NLR may be a promising prognostic indicator for GDM. However, in contrast to this, a recent study reported NLR was not a beneficial prognostic marker[47].

Liu et al reported higher NLR values among GDM patients when compared to healthy pregnant women with NLR showing an OR of 5.5[51]. A study by Ayla Aktulay et al reported significantly higher NLR and PLR in GDM compared with the control group[52]. Yilmaz et al showed increased NLR to be a powerful and independent predictor (OR 5.5) of GDM, with NLR>2.93 showing 76.2% sensitivity and 94.1% specificity in predicting GDM[53]. In 2014, a cross-sectional study indicated that NLR was independently associated with GDM. However, a few subsequent studies with a large sample size failed to find increased NLR in GDM[54]. Sargin et al found no statistical differences in NLR and PLR values between GDM patients and healthy pregnant women[55]. According to Wang et al, NLR at 4.89 cut-offs accurately predicted preeclampsia with sensitivity, specificity rates of 56.69% and 87.83%, positive and negative predictive values of 87.79% and 57.23% AUC of 0.78[47].

A meta-analysis reported elevated NLR levels in GDM compared to euglycemic pregnancies with a standardized mean difference of 0.584; however, they reported an extensive interstudy heterogeneity[56]. Another meta-analysis by Kamran et al reports that higher NLR (weighted mean difference of 0.48) was observed in GDM when compared with healthy pregnancies[57]. Further, a few studies report that the leukocyte, neutrophil, and lymphocyte counts were significantly higher in GDM patients when compared to healthy controls.

NLR has been used to predict long-term complications of diabetes and is a predictive factor for hearing loss and the development of diabetic retinopathy, early diabetic nephropathy, and coronary artery disease in patients with diabetes mellitus. However, discrepancies may be attributed to differences in age, demography, duration, and severity of hyperglycemia exposure, and any underlying inflammatory comorbidities in the patient population[55]. NLR warrants cautious clinical interpretation due to the nonspecific nature of the NLR and its implication in varied inflammatory pathophysiologies[56]. Current evidence regarding the role of NLR in GDM is controversial, and prospective cohort studies are needed to reassess the clinical utility of NLR in GDM[54] [Figure 3].


  4. NLR in ectopic pregnancy Top


4.1. Ectopic pregnancy

Ectopic pregnancy is a condition where the fetus is implanted outside the uterine cavity (98% in the fallopian tube). Ectopic pregnancy emerges as one of the leading causes of first-trimester maternal deaths accounting for 6%-10% of pregnancy-related mortality[58].

The level of inflammatory cytokines is increased both regionally and in the systemic circulation in ectopic pregnancy patients. The diagnostic gold standard for ectopic pregnancy is a combination of sonographic adnexal evaluation and serial measurements of β-hCG. A reliable maker that could effectively determine the risk of tubal rupture and stratify patients suitable for a conservative approach has been a pressing need in the obstetrics community. Literature evidence suggests that evaluating systemic inflammatory markers in combination with serum β-hCG levels and ultrasound might help decide the appropriate treatment option, and NLR might serve as an additional marker for the same[59].

4.2. Neutrophils in ectopic pregnancy

Inflammatory signaling mechanisms (leukocytes guided by cytokines, chemokines, and integrins) are involved in directing and engaging the embryo to the implantation site, including ectopic pregnancies. This causes an increase in NLR. Stress-induced neutrophilia appears to be attributed to the redistribution of neutrophils into the systemic circulation[60].

4.3. Lymphocytes in ectopic pregnancy

The observed lymphopenia is believed to be secondary to stress- induced glucocorticoid excess. Excess glucocorticoids alter the distribution of lymphocytes with increased trafficking of lymphocytes from blood to lymphoid tissue and decreased shift from lymphoid tissue to blood[61].

4.4. Significance of NLR in ectopic pregnancy

NLR has emerged as a commonly used marker of systemic inflammatory response. Dogru et al reported elevated NLR in ruptured ectopic pregnancies when compared with healthy controls[62]. Donmez et al reported that NLR was significantly higher in patients with ruptured ectopic pregnancies, with NLR greater than 4 being associated with 6.9 times higher risk of tubal rupture[62]. Another study involving 142 participants (72 patients and 70 controls) observed that NLR and PLR were significantly higher in patients with tubal rupture[59]. Further, a study concluded that NLR was significantly increased in patients requiring surgery, indicating that NLR could be a reliable risk stratification marker in ectopic pregnancies. Another study reported that ectopic pregnancy patients with tubal rupture had higher NLR than those without tubal rupture; hence, NLR can effectively assist in treatment decisions. Further, a study reported higher NLR in patients non-responsive to methotrexate treatment when compared to methotrexate responsive patients, thus indicating that NLR might be a predictor of methotrexate treatment outcome in ectopic pregnancies[54].


  5. NLR and reproduction Top


NLR is a basic inflammatory ratio that could be determined from a blood count. The ratio is commonly reported and investigated as a predictive markers in a range of diagnostic fields due to its core significance in reflecting an inflammatory load. Inflammatory reproductive diseases/conditions, such as hyperemesis gravidarum, gestational diabetes, pre-eclampsia, pregnancy-associated intrahepatic cholestasis, and other illnesses, have all been linked to an elevation in NLR. NLR might prove to be an accessible predictor of common maternal associated morbidities/complications of pregnancy.


  6. Conclusions Top


Immunological and inflammatory mechanisms lie at the heart of a successful pregnancy, and dysfunction plays a critical role in adverse pregnancy outcomes. The major players of systemic inflammation include the primary cells of the immune system, i.e., the neutrophils and lymphocytes, and hence mechanistically neutrophil-lymphocyte ratio ought to forecast an impending/ongoing inflammatory pathology. Increasing scientific evidence emphasizes that the NLR ratio has a significant role in predicting and prognosticating pregnancy-associated diseases. This simple, easily derivable, inexpensive, and valuable predictor ratio associated with the clinical picture can guide clinicians, caution about the development of pregnancy-associated inflammatory pathologies, and timely referral of these patients to the tertiary care center to avoid maternal and fetal complications. The prospective study should further explore the utility of this ratio in pregnancy-associated diseases in well-designed gestational age-adjusted reference ranges and clinical cut-offs.


  7. Future prospects Top


Trimester wise establishment of reference ranges for normal pregnancy, developing cut-off values for predicting and prognostication of high-risk pregnancy with maternal complications and development of high risk delta NLR values in serial NLR measurements.

Conflict of interest statement

The authors declare that there is no conflict of interest.

Authors’ contributions

Ms. Monalisa Biswas carried out article extraction and critical appraisal, synthesis of results from various articles, manuscript writing and editing. Dr. Vijetha Shenoy Belle conducted article extraction and critical appraisal, manuscript editing and review. Dr. Nihaal Maripini created figures for mechanistic role of NLR in various maternal complications and manuscript editing. Dr. Krishnananda Prabhu was involved in conception, intellectual inputs, review supervision, manuscript editing and review.

 
  References Top

1.
Chandra S, Tripathi AK, Mishra S, Amzarul M, Vaish AK. Physiological changes in hematological parameters during pregnancy. Indian J Hematol Blood Transfus 2012; 28(3): 144-146.  Back to cited text no. 1
    
2.
Mello G, Parretti E, Cioni R, Lagozio C, Mealli F, Pratesi M. Individual longitudinal patterns in biochemical and hematological markers for the early prediction of pre-eclampsia. J Matern Fetal Neonatal Med 2002; 11(2): 93-99.  Back to cited text no. 2
    
3.
Akinbami AA, Ajibola SO, Rabiu KA, Adewunmi AA, Dosunmu AO, Adediran A, et al. Hematological profile of normal pregnant women in Lagos, Nigeria. Int J Womens Health 2013; 5: 227-232.  Back to cited text no. 3
    
4.
Nieuwenhoven ALV, Heineman MJ, Faas MM. The immunology of successful pregnancy. Hum Reprod Update 2003; 9(4): 347-357.  Back to cited text no. 4
    
5.
Robertson SA, Petroff MG, Hunt JS. Immunology of pregnancy. In: Plant TM, Zeleznik AJ (eds). Knobil and Neill’s physiology of reproduction. 4th ed. Salt Lake City: Academic Press; 2015, p.1835-1874.  Back to cited text no. 5
    
6.
Rackaityte E, Halkias J. Mechanisms of fetal T cell tolerance and immune regulation. Front Immunol 2020; 11: 588.  Back to cited text no. 6
    
7.
Poole JA, Claman HN. Immunology of pregnancy: Implications for the mother. Clin Rev Allergy Immunol 2004; 26(3):161-170.  Back to cited text no. 7
    
8.
Dhariwal SK, Narang S, Singh K, Nema S. Evaluation of hematological indices, neutrophils, and platelets in pregnant women attending tertiary care centre. Indian J Pathol Oncol 2016; 3(2): 297-304.  Back to cited text no. 8
    
9.
Eledo BO, Buseri FI, Akhogba A. Evaluation of some hematological parameters among pregnant Ijaw women: An indigenous West African tribe. J Health Med Nurs 2015; 13: 10-17.  Back to cited text no. 9
    
10.
Chandra S, Tripathi AK, Mishra S, Amzarul M, Vaish AK. Physiological changes in hematological parameters during pregnancy. Indian J Hematol Blood Transfus 2012; 28(3): 144-146.  Back to cited text no. 10
    
11.
Kirbas A, Biberoglu A, Daglar K, Iskender C, Erkaya S, Dede H, et al. Neutrophil-to-lymphocyte ratio as a diagnostic marker of intrahepatic cholestasis of pregnancy. Eur J Obstet Gynecol Reprod Biol 2014; 180: 12-15.  Back to cited text no. 11
    
12.
Hershko Klement A, Hadi E, Asali A, Shavit T, Wiser A, Haikin E, et al. Neutrophils to lymphocytes ratio and platelets to lymphocytes ratio in pregnancy: A population study. PLoS One 2018; 13(5): e0196706.  Back to cited text no. 12
    
13.
Siristatidis C, Christoforaki V, Zafeiriou Z, Mastorakos G, Vrantza T, Daskalakis G. First trimester neutrophil-to-lymphocyte ratio (NLR) and pregnancy outcomes in medically assisted reproduction (MAR): A case control study. Gynecol Endocrinol 2019: 35(5): 434-438.  Back to cited text no. 13
    
14.
Christoforaki V, Zafeiriou Z, Daskalakis G, Katasos T, Siristatidis C. First trimester neutrophil to lymphocyte ratio (NLR) and pregnancy outcome. J Obstet Gynaecol 2020; 40(1): 59-64.  Back to cited text no. 14
    
15.
Harmon AC, Cornelius DC, Amaral LM, Faulkner JL, Cunningham MW Jr, Wallace K, et al. The role of inflammation in the pathology of preeclampsia. Clin Sci (Lond) 2016; 130(6): 409-419.  Back to cited text no. 15
    
16.
Tenório MB, Ferreira RC, Moura FA, Bueno NB, de Oliveira ACM, Goulart MOF. Cross-talk between oxidative stress and inflammation in preeclampsia. Oxid Med Cell Longev 2019; 2019: 8238727. doi: 10.1155/2019/8238727.  Back to cited text no. 16
    
17.
Sibai BM. Preeclampsia: An inflammatory syndrome? Am J Obstet Gynecol 2004; 191: 1061e2  Back to cited text no. 17
    
18.
Canzoneri BJ, Lewis DF, Groome L, Wang Y. Increased neutrophil numbers account for leukocytosis in women with preeclampsia. Am J Perinatol 2009; 26(10): 729-732.  Back to cited text no. 18
    
19.
Perucci LO, Corrêa MD, Dusse LM, Gomes KB, Sousa LP. Resolution of inflammation pathways in preeclampsia: A narrative review. Immunol Res 2017; 65: 774-789.  Back to cited text no. 19
    
20.
von Dadelszen P, Watson RWG, Noorwali F, Marshall JC, Parodo J, Farine D. Maternal neutrophil apoptosis in normal pregnancy, preeclampsia, and normotensive intrauterine growth restriction Am J Obstet Gynecol 1999; 181(2): 408-414.  Back to cited text no. 20
    
21.
Clark P, Boswell F, Greer IA. The neutrophil and preeclampsia. Semin Reprod Endocrinol 1998; 16(1): 57-64.  Back to cited text no. 21
    
22.
Sinuhe H, Stavros G, Irene H, Paul H. Neutrophil NETs in reproduction: From infertility to preeclampsia and the possibility of fetal loss. Front Immunol 2012; 3: 362.  Back to cited text no. 22
    
23.
Gille J, Williams JH, Hoffman CP. The feto-maternal lymphocyte interaction in preeclampsia and in uncomplicated pregnancy. Eur J Obstet Gynecol Reprod Biol 1977; 7(4): 227-238.  Back to cited text no. 23
    
24.
Laresgoiti-Servitje E. A leading role for the immune system in the pathophysiology of preeclampsia. J Leukoc Biol 2013; 94(2): 247-257.  Back to cited text no. 24
    
25.
Taylor EB, Sasser JM. Natural killer cells and T lymphocytes in pregnancy and pre-eclampsia. Clin Sci (Lond) 2017; 131(24): 2911-2917.  Back to cited text no. 25
    
26.
Lamarca B. The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia. Minerva Ginecol 2010; 62(2): 105-120.  Back to cited text no. 26
    
27.
Cornelius DC. Preeclampsia: From inflammation to immunoregulation. Clin Med Insights Blood Disord 2018; 11: 1179545X17752325. doi: 10.1177/1179545X17752325.  Back to cited text no. 27
    
28.
Stohl HE, Lee RH, Manetta J, Kikly K, Korst LM, Stohl W. Maternal serum B-cell activating factor levels: Candidate early biomarker for hypertensive disorders of pregnancy. Hypertension 2017; 70(5):1007- 1013.  Back to cited text no. 28
    
29.
Muzzio D, Zenclussen AC, Jensen F. The role of B cells in pregnancy: The good and the bad. Am J Reprod Immunol 2013; 69(4): 408-412.  Back to cited text no. 29
    
30.
Lima J, Martins C, Leandro MJ, Nunes G, Sousa MJ, Branco JC, et al. Characterization of B cells in healthy pregnant women from late pregnancy to post-partum: A prospective observational study. BMC Pregnancy Childbirth 2016; 16: 139.  Back to cited text no. 30
    
31.
Muzzio DO, Ziegler KB, Ehrhardt J, Zygmunt M, Jensen F. Marginal zone B cells emerge as a critical component of pregnancy well-being. Reproduction 2016; 151(1): 29-37.  Back to cited text no. 31
    
32.
Wang L, Jiang P, Zhao S, Liu H, Liu L, Mor G, et al. The dynamic profile and potential function of B-cell subsets during pregnancy. Cell Mol Immunol 2021; 18(4): 1082-1084.  Back to cited text no. 32
    
33.
Guzman-Genuino RM, Hayball JD, Diener KR. Regulatory B cells: Dark horse in pregnancy immunotherapy? J Mol Biol 2021; 433(1): 166596.  Back to cited text no. 33
    
34.
Eledel RH, Bassuoni MA, Radwan WM, Masoud A, Eldeeb SM. CD19+CD5+ B-cell expansion and risk of pre-eclampsia. Menoufia Med J 2016; 29: 319-323.  Back to cited text no. 34
    
35.
Dutta S, Sengupta P, Haque N. Reproductive immunomodulatory functions of B cells in pregnancy. Int Rev Immunol 2020; 39(2): 53-66.  Back to cited text no. 35
    
36.
Sachan R, Patel ML, Vandana, Sachan P, Shyam R. Diagnostic accuracy of neutrophil to lymphocyte ratio in prediction of nonsevere preeclampsia and severe preeclampsia. J Curr Res Sci Med 2017; 3: 79-83.  Back to cited text no. 36
    
37.
Yücel B, Ustun B. Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, mean platelet volume, red cell distribution width and plateletcrit in preeclampsia. Pregnancy Hypertens 2017; 7: 29-32.  Back to cited text no. 37
    
38.
Serin S, Avci F, Ercan O, Köstü B, Bakacak M, Kiran H. Is neutrophil/ lymphocyte ratio a useful marker to predict the severity of pre-eclampsia? Pregnancy Hypertens 2016; 6(1): 22-25.  Back to cited text no. 38
    
39.
Kang Q, Li W, Yu N, Fan L, Zhang Y, Sha M, et al. Predictive role of neutrophil-to-lymphocyte ratio in preeclampsia: A metaanalysis including 3 982 patients. Pregnancy Hypertens 2020; 20: 111-118.  Back to cited text no. 39
    
40.
Kirbas A, Ersoy AO, Daglar K, Dikici T, Biberoglu EH, Kirbas O, et al. Prediction of preeclampsia by first trimester combined test and simple complete blood count parameters. J Clin Diagn Res 2015; 9(11): QC20- QC23. doi: 10.7860/JCDR/2015/15397.6833.  Back to cited text no. 40
    
41.
Kurtoglu E, Kokcu A, Celik H, Tosun M, Malatyalioglu E. May ratio of neutrophil to lymphocyte be useful in predicting the risk of developing preeclampsia? A pilot study. J Matern Fetal Neonatal Med 2015; 28(1): 97-99.  Back to cited text no. 41
    
42.
Oylumlu M, Ozler A, Yildiz A, Oylumlu M, Acet H, Polat N, et al. New inflammatory markers in pre-eclampsia: Echocardiographic epicardial fat thickness and neutrophil to lymphocyte ratio. Clin Exp Hypertens 2014; 36(7): 503-507.  Back to cited text no. 42
    
43.
Panwar M, Kumari A, Hp A, Arora R, Singh V, Bansiwal R. Raised neutrophil lymphocyte ratio and serum beta hCG level in early second trimester of pregnancy as predictors for development and severity of preeclampsia. Drug Discov Ther 2019; 13(1): 34-37.  Back to cited text no. 43
    
44.
Gezer C, Ekin A, Ertas IE, Ozeren M, Solmaz U, Mat E, et al. High first-trimester neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are indicators for early diagnosis of preeclampsia. Ginekol Pol 2016; 87(6): 431-435.  Back to cited text no. 44
    
45.
Zheng WF, Zhan J, Chen A, Ma H, Yang H, Maharjan R. Diagnostic value of neutrophil-lymphocyte ratio in preeclampsia: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 2019; 98(51): e18496.  Back to cited text no. 45
    
46.
Stoikou M, Grimolizzi F, Giaglis S, Schäfer G, van Breda SV, Hoesli IM, et al. Gestational diabetes mellitus is associated with altered neutrophil activity. Front Immunol 2017; 8: 702.  Back to cited text no. 46
    
47.
Wang J, Zhu QW, Cheng XY, Sha CX, Cui YB. Clinical significance of neutrophil–lymphocyte ratio and monocyte–lymphocyte ratio in women with hyperglycemia, Postgrad Med 2020; 132(8): 702-708.  Back to cited text no. 47
    
48.
Alba-Loureiro TC, Munhoz CD, Martins JO, Cerchiaro GA, Scavone C, Curi R, et al. Neutrophil function and metabolism in individuals with diabetes mellitus. Braz J Med Biol Res 2007; 40(8): 1037-1044.  Back to cited text no. 48
    
49.
Wong S, Demers M, Martinod K, Gallant M, Wang Y, Goldfine AB, et al. Diabetes primes neutrophils to undergo NETosis, which impairs wound healing. Nat Med 2015; 21: 815-819.  Back to cited text no. 49
    
50.
Lou M, Luo P, Tang R, Peng Y, Yu S, Huang W, et al. Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients. BMC Endocr Disord 2015; 15: 9.  Back to cited text no. 50
    
51.
Liu W, Lou X, Zhang Z, Chai Y, Yu Q. Association of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, mean platelet volume with the risk of gestational diabetes mellitus. Gynecol Endocrinol 2021; 37(2): 105-107.  Back to cited text no. 51
    
52.
Aktulay A, Engin-Ustun Y, Ozkan MS, Erkaya S, Kara M, Kaymak O. Gestational diabetes mellitus seems to be associated with inflammation. Acta Clin Croat 2015; 54: 475-478.  Back to cited text no. 52
    
53.
Yilmaz H, Celik HT, Namuslu M, Inan O, Onaran Y, Karakurt F, et al. Benefits of the neutrophil-to-lymphocyte ratio for the prediction of gestational diabetes mellitus in pregnant women. Exp Clin Endocrinol Diabetes 2014; 122(1): 39-43.  Back to cited text no. 53
    
54.
Ling H, Hu ZD. The clinical utility of neutrophil to lymphocyte ratio in pregnancy related complications: A mini-review. J Lab Precis Med 2020; 5: 1.  Back to cited text no. 54
    
55.
Sargin MA, Yassa M, Taymur BD, Celik A, Ergun E, Tug N. Neutrophil- to-lymphocyte and platelet-to-lymphocyte ratios: Are they useful for predicting gestational diabetes mellitus during pregnancy? Ther Clin Risk Manag 2016; 12: 657-665.  Back to cited text no. 55
    
56.
Pace NP, Vassallo J. Association between neutrophil-lymphocyte ratio and gestational diabetes-A systematic review and meta-analysis. J Endocr Soc 2021; 5(7): bvab051. doi: 10.1210/jendso/bvab051.  Back to cited text no. 56
    
57.
Hessami K, Tabrizi R, Homayoon N, Hashemi A, Heydari ST, Pourhoseini SA. Gestational diabetes mellitus and inflammatory biomarkers of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio: A systematic review and meta-analysis. Biomarkers 2021; 26(6): 491-498.  Back to cited text no. 57
    
58.
Mummert T, Gnugnoli DM. Ectopic pregnancy. In: StatPearls [Online]. Treasure Island (FL): StatPearls Publishing; 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539860/. [Updated 2020 Nov 20].  Back to cited text no. 58
    
59.
Kan Ö, Gemici A, Alkilic A, Cetindag EN, Cakir C, Dur R, et al. The effect of preoperative neutrophil-to-lymphocyte ratio and platelet-to- lymphocyte ratio on predicting rupture risk in tubal ectopic pregnancies. Gynecol Obstet Invest 2019; 84(4): 378-382.  Back to cited text no. 59
    
60.
G Zini. Abnormalities in leukocyte morphology and number. In: Porwit A, McCullough J, Erber WN (eds). Blood and bone marrow pathology. 2nd ed. London: Churchill Livingstone; 2011. p. 247-261.  Back to cited text no. 60
    
61.
Boes KM, Durham AC. Bone marrow, blood cells, and the lymphoid/ lymphatic system. In: James F (ed.). Zachary, pathologic basis of veterinary disease. 6th ed. Louis, MO: Elsevier Mosby; 2017, p. 724-804.e2.  Back to cited text no. 61
    
62.
Donmez E, Arinkan S, Sut H, Iscan R, Vural F. Importance of inflammatory markers in predicting the rupture in ectopic pregnancies. EJMO 2018; 2(4): 198-202.  Back to cited text no. 62
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
Abstract
1. Introduction
2. NLR in preecl...
3. NLR in gestat...
4. NLR in ectopi...
5. NLR and repro...
6. Conclusions
7. Future prospects
References
Article Figures

 Article Access Statistics
    Viewed1681    
    Printed20    
    Emailed0    
    PDF Downloaded196    
    Comments [Add]    

Recommend this journal